These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18723234)

  • 21. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
    Shaikh F; Maddikunta R; Djelmami-Hani M; Solis J; Allaqaband S; Bajwa T
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):614-8. PubMed ID: 18360853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-acquired stent malapposition after sirolimus-eluting stent implantation following acute coronary syndrome: angiographic, IVUS, OCT and coronary angioscopic observation.
    Rathore S; Terashima M; Suzuki T
    J Invasive Cardiol; 2009 Dec; 21(12):666-7. PubMed ID: 19966371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation.
    Yang TH; Kim DI; Park SG; Seo JS; Cho HJ; Seol SH; Kim SM; Kim DK; Kim DS
    Int J Cardiol; 2009 Jan; 131(2):212-6. PubMed ID: 18241940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Stent Fracture: Still a Cause of Stent Failure.
    Pazolini V; Campos C; Caixeta A
    J Invasive Cardiol; 2019 May; 31(5):E89-E90. PubMed ID: 31034440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents.
    Codner P; Bental T; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    J Invasive Cardiol; 2014 Aug; 26(8):378-84. PubMed ID: 25091097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation.
    Kawaguchi R; Jingu M; Yamashita E; Toyama T; Hoshizaki H; Oshima S
    Circulation; 2009 Sep; 120(9):e65. PubMed ID: 19720941
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
    Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
    EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A glimpse into first generation drug-eluting and bare metal stents ten years later with optical coherence tomography analysis.
    Buccheri D; Cortese B
    Int J Cardiol; 2016 Jun; 212():129-30. PubMed ID: 27038717
    [No Abstract]   [Full Text] [Related]  

  • 31. Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.
    Naganuma T; Fujino Y; Tahara S; Mitomo S; Basavarajaiah S; Nakamura S
    JACC Cardiovasc Interv; 2015 Dec; 8(14):e237-9. PubMed ID: 26718525
    [No Abstract]   [Full Text] [Related]  

  • 32. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
    Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
    Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
    Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
    Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
    Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Yamaji K; Ando K; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Tamura T; Shirotani M; Miki S; Matsuda M; Takahashi M; Ishii K; Tanaka M; Aoyama T; Doi O; Hattori R; Kato M; Suwa S; Takizawa A; Takatsu Y; Shinoda E; Eizawa H; Takeda T; Lee JD; Inoko M; Ogawa H; Hamasaki S; Horie M; Nohara R; Kambara H; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2014 Apr; 7(2):168-79. PubMed ID: 24550439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.
    Radu MD; Räber L; Kalesan B; Muramatsu T; Kelbæk H; Heo J; Jørgensen E; Helqvist S; Farooq V; Brugaletta S; Garcia-Garcia HM; Jüni P; Saunamäki K; Windecker S; Serruys PW
    Eur Heart J; 2014 Mar; 35(12):795-807. PubMed ID: 24132187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.